Metoclopramide in the treatment of an infant with gastroesophageal hypomotility.
Pediatric patients with organic and congenital gastrointestinal disorders, including gastroesophageal reflux, may benefit from metoclopramide therapy. In addition, the weight gain, secondary to metoclopramide therapy, as experienced by the patient in this report, may enhance patient tolerance to corrective surgical procedures. Further research is necessary to define proper dosage recommendations and to determine those patients who will be successfully treated.
D005764:Gastroesophageal Reflux / Q000151:congenital / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000151:congenital / Q000188:drug therapy*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use*
D008787:Metoclopramide